These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9035996)

  • 1. [Cytolytic hepatitis during treatment with phenothiazines: apropos of a case].
    Mesure G; Bayle F; Vanelle JM; Olié JP; Lôo H
    Encephale; 1996; 22(5):388-90. PubMed ID: 9035996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatic tolerance of atypical antipsychotic drugs].
    Dumortier G; Cabaret W; Stamatiadis L; Saba G; Benadhira R; Rocamora JF; Aubriot-Delmas B; Glikman J; Januel D
    Encephale; 2002; 28(6 Pt 1):542-51. PubMed ID: 12506267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo study of the mutagenicity of biperidine, pipotiazine, chlorpromazine, and haloperidol.
    Smith M; de Souza MA; Pugliese S; Mari Jde J
    Am J Med Genet; 1996 Apr; 67(2):238. PubMed ID: 8723058
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of clozapine, haloperidol and chlorpromazine in schizophrenia during a five-year period.
    Ravanic DB; Dejanovic SM; Janjic V; Jovic SD; Milovanovic DR; Jakovljevic V; Pantovic V; Ravanic B; Pantovic M; Pantovic MM
    Arq Neuropsiquiatr; 2009 Jun; 67(2A):195-202. PubMed ID: 19547808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: a prospective study.
    Sramek JJ; Simpson GM; Morrison RL; Heiser JF
    J Clin Psychiatry; 1986 Jun; 47(6):305-9. PubMed ID: 2872206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
    Reschke RW
    Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic medication: clinical guidelines for maintenance therapy.
    Johnson DA
    J Clin Psychiatry; 1985 May; 46(5 Pt 2):6-15. PubMed ID: 2859281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia.
    Conley RR; Tamminga CA; Bartko JJ; Richardson C; Peszke M; Lingle J; Hegerty J; Love R; Gounaris C; Zaremba S
    Am J Psychiatry; 1998 Jul; 155(7):914-20. PubMed ID: 9659857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyponatremia of therapeutic origin. Apropos of a case].
    Assal F; Chauchot F
    Encephale; 1994; 20(5):527-9. PubMed ID: 7828516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug reactions experienced by out-patients taking chlorpromazine or haloperidol at Zomba Mental Hospital, Malawi.
    Chikowe I; Domingo M; Mwakaswaya V; Parveen S; Mafuta C; Kampira E
    BMC Res Notes; 2019 Jul; 12(1):376. PubMed ID: 31262359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of neuroleptics (haloperidol and chlorpromazine) on the pharmacokinetics of valproic acid in schizophrenic patients.
    Ishizaki T; Chiba K; Saito M; Kobayashi K; Iizuka R
    J Clin Psychopharmacol; 1984 Oct; 4(5):254-61. PubMed ID: 6149238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Translation and application of the Simpson and Angus Scale of Extrapyramidal Symptoms].
    Lejoyeux M; Gorwood P; Stalla-Bourdillon A; Adès J
    Encephale; 1993; 19(1):17-21. PubMed ID: 8275889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schizophrenic patients before and after HIV infection: a case-control study.
    Mauri MC; Fabiano L; Bravin S; Ricci C; Invernizzi G
    Encephale; 1997; 23(6):437-41. PubMed ID: 9488926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent sinus arrest in association with neuroleptic malignant syndrome.
    Parry AK; Ormerod LP; Hamlin GW; Saleem PT
    Br J Psychiatry; 1994 May; 164(5):689-91. PubMed ID: 7921725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Paralytic ileus during haloperidol therapy].
    Gaszner G; Kosza P
    Neuropsychopharmacol Hung; 2004 Mar; 6(1):36-8. PubMed ID: 15125313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological management of anxiety in patients suffering from schizophrenia].
    Baylé FJ; Blanc O; De Chazeron I; Lesturgeon J; Lançon C; Caci H; Garay RP; Llorca PM
    Encephale; 2011 May; 37 Suppl 1():S83-9. PubMed ID: 21600338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic dose and schizophrenic symptoms. A survey of prescribing practices.
    Peralta V; Cuesta MJ; Caro F; Martinez-Larrea A
    Acta Psychiatr Scand; 1994 Nov; 90(5):354-7. PubMed ID: 7872040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late-Onset Cholestatic Liver Injury During Combination Treatment With Chlorpromazine and Olanzapine: A Case Report.
    Dusi N; Comacchio C; Lasalvia A
    J Clin Psychopharmacol; 2019; 39(2):175-176. PubMed ID: 30640795
    [No Abstract]   [Full Text] [Related]  

  • 19. [The "neuroleptic threshold"--a review of the literature].
    Abraham D; Kissling W; Lauter H
    Psychiatr Prax; 1996 May; 23(3):109-16. PubMed ID: 8710999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological treatment of delusional depression].
    Amore M; Giordani L; Giorgetti G; Zazzeri N
    Minerva Psichiatr; 1996 Mar; 37(1):29-33. PubMed ID: 8804200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.